Clinical Trial Update: A Study to Evaluate Safety, Tolerability, and Pharmacokinetics of Fenfluramine (Hydrochloride) in Infants 1 Year to Less Than 2 Years of Age With Dravet Syndrome [Phase 3]

View source ↗

Summary

Phase 3 clinical trial evaluating safety, tolerability, and pharmacokinetics of fenfluramine in infants aged 1 to less than 2 years with Dravet syndrome.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Dravet Syndrome

Drugs mentioned

• Fenfluramine (fenfluramine)

Snippet

Sponsor: UCB BIOSCIENCES, Inc. | Conditions: Dravet Syndrome | Phase 3 | Status: ACTIVE_NOT_RECRUITING